PM
Therapeutic Areas
Nautilus Biotechnology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Voyager Platform - Broadscale Discovery Proteomics | General Proteome Analysis (Drug Target ID, Exploratory Research) | Early Access |
| Voyager Platform - Targeted Proteoform Analysis | In-depth Proteoform Analysis (e.g., Tau, alpha-synuclein in Neurodegenerative Disease) | Early Access |
| Collaboration on Alpha-Synuclein Proteoforms | Parkinson’s Disease Biomarker Discovery | Research Collaboration |
Leadership Team at Nautilus Biotechnology
SP
Sujal Patel
Founder & CEO
AM
Anna Mowry
Chief Financial Officer
KS
Ken Suzuki
Chief Marketing Officer
BS
Birgit Schilling, PhD
Professor and Director of the Mass Spectrometry Core at the Buck Institute for Research on Aging (Collaborator/Webinar Presenter)